Healthcare and Life Sciences

Format: 2016-07-27
Format: 2016-07-27
July 27, 2016 | 110 Pages | SKU: IRTNTR10076

Overview of the global asthma therapeutics market

Market research analysts at Technavio have predicted that the global asthma therapeutics market will grow steadily over the next four years and post an impressive revenue of more than USD 22 billion by 2020. Owing to the development of target specific drugs, there will be a high demand for monoclonal antibodies for the treatment of asthma. Monoclonal antibodies (mAbs) that block immunoglobulin E and specific cytokines are important in the initiation and persistence of asthmatic inflammation. Xolair was the first mAb to be approved for the treatment of allergic asthma and recorded huge sales right after approval. Since several manufacturers are currently focusing on the development of other mAbs, the forecast period will see the introduction of several new products. And owing to the better efficacy of these drugs over other small molecules, there will be an upsurge in their demand contributing to the growth of the asthma drugs market.

The Americas will account for more than 45% of the total share of the market and dominate the industry during the forecast period. The increase in pollution and the presence of a huge asthmatic population in the Latin American countries are identified to be the major factors that will augment the demand for asthmatic drugs from this region. Also, the introduction of new healthcare reforms of various countries in the region have resulted in reducing the cost of pharmaceutical drugs, providing increased access and quality of healthcare, and offer insurance coverage for individuals of all ages, which will, in turn, fuel the growth of the market in this region

July 27, 2016 | 59 Pages | SKU: IRTNTR9274

Overview of the global testosterone replacement therapy market

Technavio’s market research analyst predicts that the global testosterone replacement therapy market will generate revenues of over USD 2 billion by the end of the estimated period. A key driver influencing the growth of this market is the increased prevalence of chronic diseases around the world. Low testosterone levels can cause chronic problems like diabetes, heart disease, and can even exacerbate conditions like rheumatoid arthritis. Since these chronic conditions lead to disorders in the hypothalamic-pituitary-gonadal axis, the demand for testosterone replacement therapy will increase significantly over the next few years. This recent increase in the number of individuals with low testosterone levels will have a positive impact on the market’s growth potential during the forecast period.

In this industry report, the analysts estimate factors like the availability selective androgen receptor modulators (SARMs) to spur market growth during the forecast period. Testosterone therapies are available in injectable form or delivery through the skin. The development and free availability of SARMs are considered a better treatment option for people with androgen deficiencies. Taken orally, SARMS elicit the desired response by targeting androgen receptors. The availability of effective drug delivery systems like SARMS will propel market growth until the end of 2020.

Segmentation by dosage form and analysis of the testosterone replacement therapy market

  • Gels
  • Injectables
  • Patches

In 2015, the gels segment accounted for the largest share of the testosterone replacement therapy market with approximately 66% market share. Gels are available in a semi-solid form and contain an active ingredient, which can be applied locally for

July 27, 2016 | 79 Pages | SKU: IRTNTR9071

Overview of the methicillin-resistant Staphylococcus aureus (MRSA) drugs market

Methicillin-resistant Staphylococcus aureus (MRSA) is a skin infection that occurs mostly in hospitals and healthcare facilities.  It is treated with commonly-used antibiotics and is highly contagious. This infection is difficult to treat because it is sometimes resistant to commonly-used antibiotics such as methicillin. As per this market research report, the aging people are highly susceptible to MRSA infections, especially in the hospital environment as their weak immune system makes them easily prone to diseases and infections. The early detection of these diseases and growing awareness of their treatment drugs will positively aid to the growth of this market in the coming years. Technavio’s market research analyst predicts the global MRSA drugs market to grow at a steady CAGR of around 1% by 2020.

The surge in the number of infections and infectious diseases is creating unmet needs in the market. This has propelled government-based and non-governmental institutes to take up initiatives to develop antibiotics by providing the necessary funding to the research institutes and companies. Several nations across the globe are actively providing funds to develop antibacterial drugs and fight antibacterial drug resistance and its surveillance. Such funding encourages research institutes and companies to invest more in antibiotic research, thereby resulting in the growth of this market.

Segmentation by drug class and analysis of the MRSA drugs market

  • Tetracycline
  • Folate antagonist
  • Cephalosporin
  • Lipopeptides
  • Oxazolidinone
  • Lipoglycopeptide

Tetracyclines prevent bacterial protein synthesis by reversibly binding to the bacterial 30S ribosomes. They act against Gram-positive and Gram-negative bacteria; however, most of the

July 27, 2016 | 82 Pages | SKU: IRTNTR9338

Overview of the global eye care surgical market

Technavio’s market research analyst predicts that the global eye care surgical market will grow at a CAGR of more than 10% by 2020. The most common eye disorders include cataract, glaucoma, and diabetic retinopathy. There is a significant increase in the incidence of eye diseases across the globe, especially in industrialized and middle-income countries. With the high occurrence rate of diabetes and obesity among the youth, the chances of vision loss and several eye disorders have increased prominently. Individuals with diabetes have an increased risk of being affected by diabetic retinopathy and macular edema. This growing prevalence of diabetic eye diseases will increase the adoption several eye laser procedures, thereby positively influencing the eye care surgical market in the coming years.

The market is witnessing a considerable shift towards MI surgeries for the treatment of eye diseases. Vendors have come up with several advanced laser technologies including pattern scan laser, reduced fluence laser, short-pulse duration, and navigated laser systems for macular edema and proliferative diabetic retinopathy. These days, the ophthalmologists are using OCT to detect quantitative progression of glaucoma or macular edema in patients. Such technological advancements in laser technologies will aid in this market’s growth during the forecast period.

Segmentation by procedure and analysis of the eye care surgical market

  • Cataract surgery
  • Glaucoma surgery
  • Diabetic eye surgery

Cataract surgeries dominated the eye care surgical market in 2015, occupying more than 82% of the total market share. The primary reason for this segment’s growth is the increased adoption of different ophthalmology treatment methodologies by the aging population. Factors such as the increasing incidences of cataract

July 26, 2016 | 55 Pages | SKU: IRTNTR9881

Outlook of the global blood processing devices and consumables market

This market study anticipates the global blood processing devices and consumables market to grow at an impressive CAGR of over 8% by 2020. Increasing instances of blood transfusion surgical procedures across the globe will aid in the strong growth of this market during the estimated period. Due to changes in lifestyle, lack of immunity, and other health-related issues, direct and indirect healthcare admission for treatment of medical conditions has increased. This increase in healthcare admissions will spur the need for blood transfusion devices as it provides safe and adequate blood supply to the public and helps maintain safety standards. Furthermore, with the increase in R&D initiatives in regenerative medicine and cell therapies, the global market for blood processing devices and consumables will witness stark growth until the end of the forecast period.

In terms of geography, the global market for blood processing devices and consumables will be dominated by the Americas, which accounted for around 45% of the overall market share during 2015. The extensive use of advanced automation technologies coupled with the large-scale installation of these devices across hospitals, clinics, and blood banks in this region will result in the America’s high market dominion during the next four years. In addition, the US’s high demand for pediatric blood transfusion will also lead to the growth of this market in the region.

Competitive landscape and key vendors

This market is characterized by the presence of major healthcare companies like Abbott Laboratories, BD, and

July 25, 2016 | 98 Pages | SKU: IRTNTR9069

Outlook of the hypercholesterolemia drugs market

Extensive research carried out by the analysts at Technavio has shown that the global hypercholesterolemia drugs market is expected to reach more than USD 13 billion by 2020. Elevated levels of cholesterol in the blood lead to its deposition in the arterial walls, eventually leading to atherosclerosis. This results in the narrowing of blood vessels, decreasing blood flow to the heart muscles that might induce a heart attack. High cholesterol levels constitute for nearly one-third of the ischemic heart disease and stroke in developing nations like India and China. According to WHO, in men aged above 40 years, a 10% decrease in serum cholesterol level reduces the risk of heart disease by almost 50% within five years. Therefore, as per the cardiovascular risk management guidelines, it is imperative to reduce the blood cholesterol level to significantly lower the risk of cardiovascular diseases.

In the market research study, the analysts have estimated factors the increasing use of combination therapies to contribute to the growth of this market in the coming years. Combination drugs are mostly used for managing lipid abnormalities. Combination drugs have advantages over monotherapies both in terms of efficacy and reduced incidences of adverse effects. Also, combination drugs are priced lower, have simpler logistics distribution, and show improved patient compliance than monotherapy.

Segmentation by drug class and analysis of the hypercholesterolemia drugs market

  • Statins
  • Non-statins

During 2015, statins dominated the market and accounted for more than 80% of the market share in terms of revenue. Statins are structural analogs of the HMG-CoA enzyme and block HMG-CoA reductase enzyme activity, which catalyzes the rate-limiting step in de novo cholesterol synthesis